By Associate Professor Natasa Gisev

Journal articles

Roxburgh A; Hall WD; Gisev N; Degenhardt L, 2019, 'Characteristics and circumstances of heroin and pharmaceutical opioid overdose deaths: Comparison across opioids', Drug and Alcohol Dependence, 205, http://dx.doi.org/10.1016/j.drugalcdep.2019.06.035

Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P, 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7

Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S, 2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976

Peacock A; Chiu V; Leung J; Dobbins T; Larney S; Gisev N; Pearson SA; Degenhardt L, 2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030605

Gisev N; Bharat C; Larney S; Dobbins T; Weatherburn D; Hickman M; Farrell M; Degenhardt L, 2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', The Lancet Public Health, 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X

Lalic S; Bell JS; Gyllensten H; Gisev N; Friberg E; Ilomaki J; Sluggett JK; Mittendorfer-Rutz E; Alexanderson K, 2019, 'Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: A 10-year population-based study', Pain, 160, pp. 1224 - 1233, http://dx.doi.org/10.1097/j.pain.0000000000001500

Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L, 2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0

Lalic S; Ilomäki J; Bell JS; Korhonen MJ; Gisev N, 2019, 'Prevalence and incidence of prescription opioid analgesic use in Australia', British Journal of Clinical Pharmacology, 85, pp. 202 - 215, http://dx.doi.org/10.1111/bcp.13792

Campbell G; Lintzeris N; Gisev N; Larance B; Pearson S; Degenhardt L, 2019, 'Regulatory and other responses to the pharmaceutical opioid problem', Medical Journal of Australia, 210, http://dx.doi.org/10.5694/mja2.12047

Gisev N; Pearson SA; Dobbins T; Currow DC; Blyth F; Larney S; Dunlop A; Mattick RP; Wilson A; Degenhardt L, 2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2018-025840

Gisev N; Campbell G; Lalic S; Larney S; Peacock A; Nielsen S; Pearson SA; Degenhardt L, 2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6

Blanch B; Degenhardt L; Buckley NA; Gisev N; Dobbins T; Karanges EA; Larance B; Larney S; Pearson SA, 2018, 'Prescription opioid access patterns and factors associated with increasing number of prescribers, pharmacies, and dispensings: An observational study using pharmaceutical claims', Pain Medicine (United States), 19, pp. 1170 - 1183, http://dx.doi.org/10.1093/pm/pnx035

Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L, 2018, 'To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?', Pharmacoepidemiology and Drug Safety, 27, pp. 550 - 555, http://dx.doi.org/10.1002/pds.4329

Larance B; Gisev N; Cama E; Nelson EC; Darke S; Larney S; Degenhardt L, 2018, 'Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence', Drug and Alcohol Dependence

Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L, 2018, 'A nationwide study of the extent and factors associated with fentanyl use in Australia', Research in Social and Administrative Pharmacy, 14, pp. 303 - 308, http://dx.doi.org/10.1016/j.sapharm.2017.04.002

Lalic S; Gisev N; Bell JS; Korhonen M; Ilomaki J, 2018, 'Predictors of persistent prescription opioid analgesic use among people without cancer in Australia', British Journal of Clinical Pharmacology, 84, pp. 1267 - 1278, http://dx.doi.org/10.1111/bcp.13556

Lalic S; Jokanovic N; Ilomäki J; Gisev N; Lloyd B; Lubman DI; Bell JS, 2018, 'Harms associated with extramedical use of prescription opioid analgesics in Australia: A scoping review', Research in Social and Administrative Pharmacy, http://dx.doi.org/10.1016/j.sapharm.2018.07.001

Larance B; Degenhardt L; Peacock A; Gisev N; Mattick R; Colledge S; Campbell G, 2017, 'Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.12617

Roxburgh A; Hall WD; Dobbins T; Gisev N; Burns L; Pearson S; Degenhardt L, 2017, 'Trends in heroin and pharmaceutical opioid overdose deaths in Australia', Drug and Alcohol Dependence, 179, pp. 291 - 298, http://dx.doi.org/10.1016/j.drugalcdep.2017.07.018

Nielsen S; Gisev N; Bruno R; Hall W; Cohen M; Larance B; Campbell G; Shanahan M; Blyth F; Lintzeris N; Pearson S; Mattick R; Degenhardt L, 2017, 'Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment', Pharmacoepidemiology and Drug Safety, 26, pp. 587 - 591, http://dx.doi.org/10.1002/pds.4168

Nielsen S; Degenhardt L; Hoban B; Gisev N, 2016, 'A synthesis of oral morphine equivalents (OME) for opioid utilisation studies', Pharmacoepidemiology and Drug Safety, 25, pp. 733 - 737, http://dx.doi.org/10.1002/pds.3945

Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R, 2016, 'The extent and correlates of community-based pharmaceutical opioid utilisation in Australia', Pharmacoepidemiology and Drug Safety, 25, pp. 521 - 538, http://dx.doi.org/10.1002/pds.3931

Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L, 2016, 'An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia', European Journal of Clinical Pharmacology, 72, pp. 469 - 494, http://dx.doi.org/10.1007/s00228-015-1995-8

Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026

Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L, 2015, 'A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence', Addiction, 110, pp. 1975 - 1984, http://dx.doi.org/10.1111/add.13073

Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716

Gisev N; Larney S; Kimber J; Burns L; Weatherburn D; Gibson A; Dobbins T; Mattick RP; Butler T; Degenhardt L, 2015, 'Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study', Trends and Issues in Crime and Criminal Justice

Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L, 2015, 'A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia', Addiction, 110, pp. 646 - 655, http://dx.doi.org/10.1111/add.12834

Nielsen S; Degenhardt L; Hoban B; Gisev N, 2015, 'A synthesis of oral morphine equivalents (OME) for opioid utilisation studies', Pharmacoepidemiology and Drug Safety, 25, pp. 733 - 737, http://dx.doi.org/10.1002/pds.3945

Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S, 2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, 5, pp. e007030, http://dx.doi.org/10.1136/bmjopen-2014-007030

Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2015, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', Drug and Alcohol Dependence, 146, pp. e168 - e168, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.373

Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2015, 'The impact of opioid substitution therapy on mortality post-release from prison', Drug and Alcohol Dependence, 146, pp. e260 - e260, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.173

Gisev N; Gibson A; Larney S; Kimber J; Williams M; Clifford A; Doyle M; Burns L; Butler T; Weatherburn DJ; Degenhardt L, 2014, 'Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: Comparison of Indigenous and non-Indigenous Australians', BMC Public Health, 14, pp. 920, http://dx.doi.org/10.1186/1471-2458-14-920

Gisev N; Bell JS; Chen TF, 2014, 'A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order', International Journal of Clinical Practice, 68, pp. 236 - 244, http://dx.doi.org/10.1111/ijcp.12276

Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L, 2014, 'A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women', Drug and Alcohol Review, 33, pp. 499 - 505, http://dx.doi.org/10.1111/dar.12151

Gisev N; Bell JS; Chen TF, 2014, 'Factors associated with antipsychotic polypharmacy and high-dose antipsychotics among individuals receiving compulsory treatment in the community', Journal of Clinical Psychopharmacology, 34, pp. 307 - 312, http://dx.doi.org/10.1097/JCP.0000000000000098

Degenhardt L; Larney S; Gisev N; Trevena J; Burns L; Kimber J; Shanahan M; Butler T; Mattick RP; Weatherburn D, 2014, 'Imprisonment of opioid-dependent people in New South Wales, Australia, 2000-2012: A retrospective linkage study', Australian and New Zealand Journal of Public Health, 38, pp. 165 - 170, http://dx.doi.org/10.1111/1753-6405.12123

Larney S; Gisev N; Farrell M; Dobbins T; Burns L; Gibson A; Kimber J; Degenhardt L, 2014, 'Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study', BMJ Open, 4, http://dx.doi.org/10.1136/bmjopen-2013-004666

Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L, 2014, 'The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study', Addiction, 109, pp. 1306 - 1317, http://dx.doi.org/10.1111/add.12536

Gisev N; Bell S; Chen T, 2013, 'Psychotropic drug-regimen changes between community treatment orders', Australasian Psychiatry, 21, pp. 411 - 412, http://dx.doi.org/10.1177/1039856213491845

Gisev N; Bell JS; Chen TF, 2013, 'Interrater agreement and interrater reliability: Key concepts, approaches, and applications', Research in Social and Administrative Pharmacy, 9, pp. 330 - 338, http://dx.doi.org/10.1016/j.sapharm.2012.04.004

Degenhardt LJ; Gisev N; Trevena J; Larney S; Kimber J; Burns LA; Shanahan M; Weatherburn D, 2013, 'Engagement with the criminal justice system among opioid dependent people: Retrospective cohort study', Addiction, 108, pp. 2152 - 2165, http://dx.doi.org/10.1111/add.12324

Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2012, 'Effect of comorbidity on the risk of death associated with antipsychotic use among community-dwelling older adults', International Psychogeriatrics, 24, pp. 1058 - 1064, http://dx.doi.org/10.1017/S1041610212000117

Gisev N; Hartikainen S; Chen TF; Korhonen M; Bell JS, 2011, 'Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: A population-based retrospective cohort study', Canadian Journal of Psychiatry, 56, pp. 377 - 381, http://dx.doi.org/10.1177/070674371105600609

Gisev N; Bell JS; O'Reilly CL; Rosen A; Chen TF, 2010, 'An expert panel assessment of comprehensive medication reviews for clients of community mental health teams', Social Psychiatry and Psychiatric Epidemiology, 45, pp. 1071 - 1079, http://dx.doi.org/10.1007/s00127-009-0148-8

Chen TF; Gisev N; O'Reilly C; Nishtala P; Bell JS, 2009, 'Mind games: Pharmacists and mental health', Australian Journal of Pharmacy, 90, pp. 70 - 72

Gisev N; Bell JS; McLachlan AJ; Chetty M; Chen TF, 2006, 'Psychiatric drug use among patients of a community mental health service: Patterns and implications', Disease Management and Health Outcomes, 14, pp. 369 - 376, http://dx.doi.org/10.2165/00115677-200614060-00006

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International journal of population data science, 7

Back to profile page